Skip to main content
OpenTrials

Clinical trial condition

Neisseriaceae Infections

Explore clinical trials studying Neisseriaceae Infections. Study availability and eligibility vary by location and protocol.

400 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Neisseriaceae Infections trial results

Completed

Combined Study - Phase 3b MenB Long Term Persistence in Adolescents

NCT02446743

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Diseases, +8 more
Locations
  • GSK Investigational Site Sherwood, Queensland, Australia
  • GSK Investigational Site North Adelaide, South Australia, Australia
  • GSK Investigational Site Carlton, Victoria, Australia
  • GSK Investigational Site Subiaco, Western Australia, Australia
View Trial Details
Completed

Safety and Immunogenicity of 2 or 3 Doses of MenACWY Conjugate Vaccine in Healthy Infants and the Effects of a Booster Dose of MenACWY Administered in the Second Year of Life

NCT01214837

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +13 more
Locations
  • Birmingham, Alabama, United States
  • Fayetteville, Arkansas, United States
  • Jonesboro, Arkansas, United States
  • Little Rock, Arkansas, United States
View all 40 locations
View Trial Details
Completed

Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of Booster Doses of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received One or Four Doses of the Same Vaccine

NCT01027351

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital Oxford, United Kingdom
View Trial Details
Completed

Immunogenicity and Safety of MenACWY in Infants (6 & 12 Months)

NCT00310856

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations
  • Children's Hospital of Eastern Ontario Research Institute Ottawa, Ontario, Canada
  • Herridge Community Health Clinic Ottawa, Ontario, Canada
  • Clinical Trials Research Center, Department of Pediatrics, Dalhousie University, IWK Health Center Halifax, Canada
View Trial Details
Completed

Safety and Immunogenicity of Meningococcal ACWY Conjugate Versus Polysaccharide Vaccine in Children 2 to 10 Years of Age

NCT00329849

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
Locations
  • FUNCEI, French 3085 Buenos Aires, Argentina
  • Centro di Desarrollo de Proyectos Avanzados (CEDEPAP) Roma 1464 Córdoba, Argentina
  • Hospital de Pediatria "Sor Maria Ludovica", Calle 14 N1631,(1900) La Plata, Argentina
View Trial Details
Completed

Assessing the Effectiveness, Immunogenicity and Safety of Meningococcal ABCWY Vaccine Administered to Healthy Adolescents

NCT02285777

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • GSK Investigational Site Huntsville, Alabama, United States
  • GSK Investigational Site Jonesboro, Arkansas, United States
  • GSK Investigational Site Melbourne, Florida, United States
  • GSK Investigational Site Newton, Kansas, United States
View Trial Details
Completed

Immuno,Safety of GSK Vaccine 134612 Given at Age of 12-15 Months 15-18 Months Post-priming With GSK Vaccine 792014

NCT00614614

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Dothan, Alabama, United States
  • GSK Investigational Site Benton, Arkansas, United States
View all 56 locations
View Trial Details

Related conditions